Portal de Periódicos da CAPES

A potential silver lining of delaying the second dose

2022; Nature Portfolio; Volume: 23; Issue: 3 Linguagem: Inglês

10.1038/s41590-022-01143-z

1529-2916

David R. Martinez, Eng Eong Ooi,

Bacillus and Francisella bacterial research

A delayed second dose relative to the standard 3-week schedule for the BNT162b2 mRNA vaccine against SARS-CoV-2 significantly raises the levels of neutralizing antibodies against SARS-CoV-2 variants.